Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 649 institutions that hold shares in the stock, with a total of 97.6 Million shares, which have been reported (via 13F filing form) to have a value of $12.5 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
14,190,708
shares
|
$1.82 Billion
0.04% of portfolio
|
Q2 2024
Added 3.12%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
9,941,887
shares
|
$1.27 Billion
0.02% of portfolio
|
Q1 2025
Reduced 1.76%
|
|
|
Dodge & Cox
San Francisco, CA |
May 14, 2025 Q1 2025 |
5,534,624
shares
|
$708 Million
0.37% of portfolio
|
Q1 2025
Added 83.48%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
4,862,116
shares
|
$622 Million
0.02% of portfolio
|
Q1 2025
Reduced 0.59%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
2,670,998
shares
|
$342 Million
0.02% of portfolio
|
Q1 2025
Added 94.79%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
2,502,697
shares
|
$320 Million
0.44% of portfolio
|
Q1 2025
Added 0.53%
|
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
2,097,981
shares
|
$269 Million
0.05% of portfolio
|
Q1 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,969,754
shares
|
$252 Million
0.02% of portfolio
|
Q1 2025
Added 5.05%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
May 14, 2025 Q1 2025 |
1,820,000
shares
|
$233 Million
4.67% of portfolio
|
Q4 2024
Reduced 2.35%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
1,539,601
shares
|
$197 Million
0.02% of portfolio
|
Q1 2025
Added 3.29%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,518,237
shares
|
$194 Million
0.01% of portfolio
|
Q1 2025
Reduced 3.5%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
May 15, 2025 Q1 2025 |
1,489,000
shares
|
$191 Million
4.17% of portfolio
|
Q1 2025
Added 72.74%
|
|
|
Eaton Vance Management
Boston, MA |
Nov 14, 2022 Q3 2022 |
1,347,820
shares
|
$173 Million
0.21% of portfolio
|
Q3 2022
Reduced 8.29%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
May 13, 2025 Q1 2025 |
1,255,106
shares
|
$161 Million
0.37% of portfolio
|
Q1 2025
Added 32.85%
|
|
|
Braidwell LP
Stamford, CT |
May 15, 2025 Q1 2025 |
1,191,925
shares
|
$153 Million
8.09% of portfolio
|
Q1 2025
Added 32.17%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
1,159,367
shares
|
$148 Million
0.03% of portfolio
|
Q1 2025
Added 8.34%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
1,074,630
shares
|
$138 Million
0.12% of portfolio
|
Q1 2025
Reduced 43.35%
|
|
|
Armistice Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
1,000,190
shares
|
$128 Million
1.69% of portfolio
|
Q1 2025
Added 12.13%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
957,280
shares
|
$123 Million
0.02% of portfolio
|
Q1 2025
Reduced 2.51%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
934,640
shares
|
$120 Million
3.22% of portfolio
|
Q1 2025
Reduced 0.37%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
924,416
shares
|
$118 Million
0.1% of portfolio
|
Q2 2023
Added 27.64%
|
|
|
Brown Advisory Inc
|
Apr 29, 2025 Q1 2025 |
895,542
shares
|
$115 Million
0.15% of portfolio
|
Q1 2025
Reduced 0.31%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
889,028
shares
|
$114 Million
0.02% of portfolio
|
Q1 2025
Reduced 64.97%
|
|
|
Jennison Associates LLC
|
May 02, 2025 Q1 2025 |
804,466
shares
|
$103 Million
0.06% of portfolio
|
Q1 2025
Reduced 1.98%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
May 13, 2025 Q1 2025 |
792,482
shares
|
$101 Million
0.03% of portfolio
|
Q1 2025
Reduced 6.09%
|